MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/21678421.2025.2533881

Медицинская библиотека · Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025

Fatigue in amyotrophic lateral sclerosis/motor neuron disease: prevalence, influences and trajectories.

Young Carolyn A, Chaouch Amina, Mcdermott Christopher J, Al-Chalabi Ammar, Chhetri Suresh Kumar, Bidder Caroline, Ellis Cathy, Annadale Joe, Mills Roger J, Tennant Alan, Tonic Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Objective

In a large cohort of people with amyotrophic lateral sclerosis/motor neuron disease (pwALS), we examined the age-sex prevalence of fatigue, its relationship to other symptoms and functioning, and trajectories over time.

Methods

Data from the Trajectories of Outcome in Neurological Conditions study were analyzed by Rasch analysis, structural equation and group-based trajectory models.

Results

Fatigue was reported by 97.8% on Neurological Fatigue Index-MND (NFI-MND) and 96.4% on Numeric Rating Scale Fatigue among 1058 pwALS: mean age 65 (range 20-90); mean duration 23 months (range 0-301); 60.7% male; onset 26.5% Bulbar, 71.5% Limb and 2.0% Respiratory. Mean (metric) level on NFI-MND was 12.8 (SD 5.3; range 0-24). Cut-points on the NFI-MND of 10 and 15 divided fatigue into mild (27.3%); moderate (36.1%) and severe (36.2%). Structural equation modeling showed that function, cognition, spasticity, dyspnea and pain have descending order of effect. Over average 11.6 months follow-up, 60.5% had stable fatigue, 23.8% increased fatigue level, while 15.8% showed declining fatigue. Trajectory analysis showed three groups, low, average and high fatigue. Those with low trajectories had less spasticity, worry, cognitive problems, as well as better functioning, longer duration and were less likely to be male. High fatigue trajectory was associated with worse spasticity, cognition and anxiety.

Conclusions

Fatigue is extremely common among pwALS, thus more work is required on fatigue management. In addition to treating fatigue itself, the current study shows that targeting cognition, spasticity, dyspnea and pain might be fruitful.

Для цитирования: Young Carolyn A, Chaouch Amina, Mcdermott Christopher J, Al-Chalabi Ammar, Chhetri Suresh Kumar, Bidder Caroline, Ellis Cathy, Annadale Joe, Mills Roger J, Tennant Alan, Tonic Study Group. Fatigue in amyotrophic lateral sclerosis/motor neuron disease: prevalence, influences and trajectories.. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2025. DOI: 10.1080/21678421.2025.2533881.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.